This report outlines KPMG viewpoints, as well as those of senior executives in China’s life sciences sector, on the prospects of the industry.
China’s life sciences industry has expanded at a faster rate than the economy as a whole. It remains one of the most buoyant sectors.
KPMG China interviewed a number of senior executives in producing Life Sciences: the CEO’s Perspective. This publication highlights key trends in the industry such as reforms to the drug tendering process and advances in data analytics and other technologies.
© 2020 KPMG Huazhen LLP, a People's Republic of China partnership, KPMG Advisory (China) Limited, a limited liability company in China, KPMG, a Macau partnership and KPMG, a Hong Kong partnership, are member firms of the KPMG global organisation of independent member firms affiliated with KPMG International Limited ("KPMG International"), a private English company limited by guarantee. All rights reserved. The KPMG name and logo are registered trademarks or trademarks of KPMG International.
For more detail about the structure of the KPMG global organisation please visit https://home.kpmg/governance.